메뉴 건너뛰기




Volumn 25, Issue 12, 2000, Pages 1233-1241

Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE® STn-KLH cancer vaccine

Author keywords

Autologous transplant; Breast cancer; Cancer vaccine; Immunotherapy; Ovarian cancer; Sialyl Tn; Stem cell rescue

Indexed keywords

CANCER VACCINE; DETOX B; THERATOPE STN-KLH; UNCLASSIFIED DRUG;

EID: 0033935785     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702430     Document Type: Article
Times cited : (79)

References (35)
  • 1
    • 0030901014 scopus 로고    scopus 로고
    • High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: A multivariate analysis of survival for 100 consecutively treated patients
    • Stiff PJ, Bayer R, Kerger C et al. High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients. J Clin Oncol 1997; 15: 1309-1317.
    • (1997) J Clin Oncol , vol.15 , pp. 1309-1317
    • Stiff, P.J.1    Bayer, R.2    Kerger, C.3
  • 2
    • 0031766638 scopus 로고    scopus 로고
    • High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer
    • Holmberg LA, Demirer T, Rowley S et al. High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer. Bone Marrow Transplant 1998; 22: 651-659.
    • (1998) Bone Marrow Transplant , vol.22 , pp. 651-659
    • Holmberg, L.A.1    Demirer, T.2    Rowley, S.3
  • 3
    • 0030979431 scopus 로고    scopus 로고
    • High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America
    • Antman KH, Rowlings PA, Vaughan WP et al. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol 1997; 15: 1870-1879.
    • (1997) J Clin Oncol , vol.15 , pp. 1870-1879
    • Antman, K.H.1    Rowlings, P.A.2    Vaughan, W.P.3
  • 4
    • 0030800390 scopus 로고    scopus 로고
    • High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer
    • Bensinger WI, Schiffman KS, Holmberg L et al. High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer. Bone Marrow Transplant 1997; 19: 1183-1189.
    • (1997) Bone Marrow Transplant , vol.19 , pp. 1183-1189
    • Bensinger, W.I.1    Schiffman, K.S.2    Holmberg, L.3
  • 5
    • 0027471156 scopus 로고
    • Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
    • Brenner MK, Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85-86.
    • (1993) Lancet , vol.341 , pp. 85-86
    • Brenner, M.K.1    Rill, D.R.2    Moen, R.C.3
  • 6
    • 0028131274 scopus 로고
    • Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid
    • Borges E, Wiesmuller KH, Jung G, Walden P. Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid. J Immunol Meth 1994; 173: 253-263.
    • (1994) J Immunol Meth , vol.173 , pp. 253-263
    • Borges, E.1    Wiesmuller, K.H.2    Jung, G.3    Walden, P.4
  • 7
    • 0030996710 scopus 로고    scopus 로고
    • Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A
    • Cormier JN, Salgaller ML, Prevette T et al. Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A. Cancer J Sci Am 1997; 3: 37-44.
    • (1997) Cancer J Sci Am , vol.3 , pp. 37-44
    • Cormier, J.N.1    Salgaller, M.L.2    Prevette, T.3
  • 8
    • 0026650448 scopus 로고
    • Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine
    • Kantor J, Irvine K, Abrams S et al. Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine. J Natl Cancer Inst 1992; 84: 1084-1091.
    • (1992) J Natl Cancer Inst , vol.84 , pp. 1084-1091
    • Kantor, J.1    Irvine, K.2    Abrams, S.3
  • 9
    • 0029042336 scopus 로고
    • Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaceinia-CEA vaccine
    • Tsang KY, Zaremba S, Nieroda CA et al. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaceinia-CEA vaccine. J Natl Cancer Inst 1995; 87: 982-990.
    • (1995) J Natl Cancer Inst , vol.87 , pp. 982-990
    • Tsang, K.Y.1    Zaremba, S.2    Nieroda, C.A.3
  • 10
    • 0028205790 scopus 로고
    • Improved survival in stage III melanoma patients with GM2 antibodies: A randomised trial of adjuvant vaccination with GM2 ganglioside
    • Livingston PO, Wong GY, Adluri S et al. Improved survival in stage III melanoma patients with GM2 antibodies: a randomised trial of adjuvant vaccination with GM2 ganglioside. J Clin Oncol 1994; 12: 1036-1044.
    • (1994) J Clin Oncol , vol.12 , pp. 1036-1044
    • Livingston, P.O.1    Wong, G.Y.2    Adluri, S.3
  • 11
    • 0027478209 scopus 로고
    • Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant
    • MacLean GD, Reddish M, Koganty RR et al. Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant. Cancer Immunol Immunother 1993; 36: 215-222.
    • (1993) Cancer Immunol Immunother , vol.36 , pp. 215-222
    • MacLean, G.D.1    Reddish, M.2    Koganty, R.R.3
  • 12
    • 0027275052 scopus 로고
    • Immune responses of mice and human breast cancer patients following immunisation with synthetic sialyl-Tn conjugated to KLH plus detox adjuvant
    • Longenecker BM, Reddish M, Koganty R, MacLean GD. Immune responses of mice and human breast cancer patients following immunisation with synthetic sialyl-Tn conjugated to KLH plus detox adjuvant. Ann NY Acad Sci 1993; 690: 276-291.
    • (1993) Ann NY Acad Sci , vol.690 , pp. 276-291
    • Longenecker, B.M.1    Reddish, M.2    Koganty, R.3    MacLean, G.D.4
  • 13
    • 0029873154 scopus 로고    scopus 로고
    • Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine
    • MacLean GD, Reddish MA, Koganty RR, Longenecker BM. Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine. J Immunother Emph Tumor Immunol 1996; 19: 59-68.
    • (1996) J Immunother Emph Tumor Immunol , vol.19 , pp. 59-68
    • MacLean, G.D.1    Reddish, M.A.2    Koganty, R.R.3    Longenecker, B.M.4
  • 14
    • 0029787977 scopus 로고    scopus 로고
    • Enhancing the effect of THERATOPE STn-KLH cancer vaccine in patients with metastatic breast cancer by pretreatmem with low-dose intravenous cyclophosphamide
    • MacLean GD, Miles DW, Rubens RD et al. Enhancing the effect of THERATOPE STn-KLH cancer vaccine in patients with metastatic breast cancer by pretreatmem with low-dose intravenous cyclophosphamide. J Immunother Emph Tumor Immunol 1996; 19: 309-316.
    • (1996) J Immunother Emph Tumor Immunol , vol.19 , pp. 309-316
    • MacLean, G.D.1    Miles, D.W.2    Rubens, R.D.3
  • 15
    • 0027768747 scopus 로고
    • Synthetic tumor-associated sialyl-Tn antigen as an immunotherapeutic cancer vaccine
    • Longenecker BM, Reddish M, Miles D, MacLean GD. Synthetic tumor-associated sialyl-Tn antigen as an immunotherapeutic cancer vaccine. Vaccine Res 1993; 2: 151-162.
    • (1993) Vaccine Res , vol.2 , pp. 151-162
    • Longenecker, B.M.1    Reddish, M.2    Miles, D.3    MacLean, G.D.4
  • 16
    • 0022457641 scopus 로고
    • Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3
    • Thor A, Ohuchi N, Szpak CA et al. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res 1986; 46: 3118-3124.
    • (1986) Cancer Res , vol.46 , pp. 3118-3124
    • Thor, A.1    Ohuchi, N.2    Szpak, C.A.3
  • 17
    • 0030857022 scopus 로고    scopus 로고
    • Specificities of anti-sialyl-Tn and anti-Tn monoclonal antibodies generated using novel clustered synthetic glycopeptide epitopes
    • Reddish MA, Jackson L, Koganty RR et al. Specificities of anti-sialyl-Tn and anti-Tn monoclonal antibodies generated using novel clustered synthetic glycopeptide epitopes. Glycoconj J 1997; 14: 549-560.
    • (1997) Glycoconj J , vol.14 , pp. 549-560
    • Reddish, M.A.1    Jackson, L.2    Koganty, R.R.3
  • 18
    • 0026531757 scopus 로고
    • Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer
    • Kobayashi H, Terao T, Kawashima Y. Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer. J Clin Oncol 1992; 10: 95-101.
    • (1992) J Clin Oncol , vol.10 , pp. 95-101
    • Kobayashi, H.1    Terao, T.2    Kawashima, Y.3
  • 19
    • 0032963634 scopus 로고    scopus 로고
    • Selection of carbohydrate antigens in human epithelial ovarian cancers as targets for immunotherapy: Serous and mucinous tumors exhibit distinctive patterns of expression
    • Federici MF, Kudryashov V, Saigo PE et al. Selection of carbohydrate antigens in human epithelial ovarian cancers as targets for immunotherapy: serous and mucinous tumors exhibit distinctive patterns of expression. Int J Cancer 1999; 81: 193-198.
    • (1999) Int J Cancer , vol.81 , pp. 193-198
    • Federici, M.F.1    Kudryashov, V.2    Saigo, P.E.3
  • 20
    • 0027263949 scopus 로고
    • Immunohistochemical evaluation of sialosyl-Tn antigens in various ovarian carcinomas
    • Ryuko K, Iwanari O, Kitao M, Moriwaki S. Immunohistochemical evaluation of sialosyl-Tn antigens in various ovarian carcinomas. Gynecol Oncol 1993; 49: 215-224.
    • (1993) Gynecol Oncol , vol.49 , pp. 215-224
    • Ryuko, K.1    Iwanari, O.2    Kitao, M.3    Moriwaki, S.4
  • 21
    • 0026344051 scopus 로고
    • Expression of Tn and sialyl-Tn antigens in tumor tissues of the ovary
    • Inoue M, Ton SM, Ogawa H, Tanizawa O. Expression of Tn and sialyl-Tn antigens in tumor tissues of the ovary. Am J Clin Pathol 1991; 96: 711-716.
    • (1991) Am J Clin Pathol , vol.96 , pp. 711-716
    • Inoue, M.1    Ton, S.M.2    Ogawa, H.3    Tanizawa, O.4
  • 22
    • 0028075832 scopus 로고
    • Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancer
    • Miles DW, Happerfield LC, Smith P et al. Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancer. Br J Cancer 1994; 70: 1272-1275.
    • (1994) Br J Cancer , vol.70 , pp. 1272-1275
    • Miles, D.W.1    Happerfield, L.C.2    Smith, P.3
  • 23
    • 0029743771 scopus 로고    scopus 로고
    • + lymphocytes correlate with effects of Theratope sialyl-Tn-KLH cancer vaccine in active specific immunotherapy
    • + lymphocytes correlate with effects of Theratope sialyl-Tn-KLH cancer vaccine in active specific immunotherapy. Cancer Immunol Immunother 1996; 42: 303-309.
    • (1996) Cancer Immunol Immunother , vol.42 , pp. 303-309
    • Reddish, M.A.1    MacLean, G.D.2    Poppema, S.3
  • 24
    • 0029017886 scopus 로고
    • + activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: Correlations with survival following active specific immunotherapy
    • + activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: correlations with survival following active specific immunotherapy. Int J Cancer 1995; 61: 470-474.
    • (1995) Int J Cancer , vol.61 , pp. 470-474
    • Yacyshyn, M.B.1    Poppema, S.2    Berg, A.3
  • 25
    • 0029804156 scopus 로고    scopus 로고
    • A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer
    • Miles DW, Towlson KE, Graham R et al. A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer. Br J Cancer 1996; 74: 1292-1296.
    • (1996) Br J Cancer , vol.74 , pp. 1292-1296
    • Miles, D.W.1    Towlson, K.E.2    Graham, R.3
  • 26
    • 0026596442 scopus 로고
    • Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen
    • MacLean GD, Samuel J, Meikle A et al. Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen. J Immunother 1992; 11: 292-305.
    • (1992) J Immunother , vol.11 , pp. 292-305
    • MacLean, G.D.1    Samuel, J.2    Meikle, A.3
  • 27
    • 0023489992 scopus 로고
    • T cell recognition of a tumor-associated glycoprotein and its synthetic carbohydrate epitopes: Stimulation of anticancer T cell immunity in vivo
    • Henningsson CM, Selvaras S, MacLean GD et al. T cell recognition of a tumor-associated glycoprotein and its synthetic carbohydrate epitopes: stimulation of anticancer T cell immunity in vivo. Cancer Immunol Immunother 1987; 25: 231-241.
    • (1987) Cancer Immunol Immunother , vol.25 , pp. 231-241
    • Henningsson, C.M.1    Selvaras, S.2    MacLean, G.D.3
  • 28
    • 0030854842 scopus 로고    scopus 로고
    • T-cell recognition of tumor-associated carbohydrates: The nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity
    • Galli-Stampino L, Meinjohanns E, Frische K et al. T-cell recognition of tumor-associated carbohydrates: the nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity. Cancer Res 1997; 57: 3214-3222.
    • (1997) Cancer Res , vol.57 , pp. 3214-3222
    • Galli-Stampino, L.1    Meinjohanns, E.2    Frische, K.3
  • 29
    • 0031914321 scopus 로고    scopus 로고
    • Cancer-associated MUCI mucin inhibits human T-cell proliferation, which is reversible by IL-2
    • Agrawal B, Krantz MJ, Reddish MA, Longenecker BM. Cancer-associated MUCI mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nature Med 1998; 4: 43-49.
    • (1998) Nature Med , vol.4 , pp. 43-49
    • Agrawal, B.1    Krantz, M.J.2    Reddish, M.A.3    Longenecker, B.M.4
  • 30
    • 0000021742 scopus 로고    scopus 로고
    • Immunological reconstitution after hemopoietic stem cell transplantation
    • Atkinson K (ed). Cambridge University Press: Cambridge, UK
    • Storek J, Witherspoon RP. Immunological reconstitution after hemopoietic stem cell transplantation. In: Atkinson K (ed). Clinical Bone Marrow and Blood Stem Cell Transplantation: A Reference Textbook. Cambridge University Press: Cambridge, UK, 2000, pp 111-146.
    • (2000) Clinical Bone Marrow and Blood Stem Cell Transplantation: A Reference Textbook , pp. 111-146
    • Storek, J.1    Witherspoon, R.P.2
  • 31
    • 0032943932 scopus 로고    scopus 로고
    • Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with theratope STn-KLH cancer vaccine
    • Sandmaier BM, Oparin DV, Holmberg LA et al. Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with theratope STn-KLH cancer vaccine. J Immunother 1999; 22: 54-66.
    • (1999) J Immunother , vol.22 , pp. 54-66
    • Sandmaier, B.M.1    Oparin, D.V.2    Holmberg, L.A.3
  • 33
    • 0026693788 scopus 로고
    • Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients
    • Barra A, Cordonnier C, Preziosi MP et al. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. J Infect Dis 1992; 166: 1021-1028.
    • (1992) J Infect Dis , vol.166 , pp. 1021-1028
    • Barra, A.1    Cordonnier, C.2    Preziosi, M.P.3
  • 34
    • 0021338386 scopus 로고
    • Recovery of in vivo cellular immunity after human marrow grafting: Influence of time postgrafting and acute graft-versus-host disease
    • Witherspoon RP, Matthews D, Storb R et al. Recovery of in vivo cellular immunity after human marrow grafting: influence of time postgrafting and acute graft-versus-host disease. Transplantation 1984; 37: 145-150.
    • (1984) Transplantation , vol.37 , pp. 145-150
    • Witherspoon, R.P.1    Matthews, D.2    Storb, R.3
  • 35
    • 0025347511 scopus 로고
    • Reconstruction of the haemopoietic and immune systems after marrow transplantation
    • Atkinson K. Reconstruction of the haemopoietic and immune systems after marrow transplantation (review). Bone Marrow Transplant 1990; 5: 209-226.
    • (1990) Bone Marrow Transplant , vol.5 , pp. 209-226
    • Atkinson, K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.